Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Viral hemorrhagic fevers: advancing the level of treatment

  • Giuseppe Ippolito1Email author,
  • Heinz Feldmann2,
  • Simone Lanini1Email author,
  • Francesco Vairo1, 3,
  • Antonino Di Caro1,
  • Maria Rosaria Capobianchi1 and
  • Emanuele Nicastri1
BMC Medicine201210:31

DOI: 10.1186/1741-7015-10-31

Received: 14 November 2011

Accepted: 29 March 2012

Published: 29 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Jan 2012 Reviewed Reviewer Report - Stefan Kunz
12 Jan 2012 Reviewed Reviewer Report - W. Ian Lipkin
5 Feb 2012 Author responded Author comments - SIMONE LANINI
Resubmission - Version 3
5 Feb 2012 Submitted Manuscript version 3
24 Feb 2012 Reviewed Reviewer Report - Stefan Kunz
5 Mar 2012 Author responded Author comments - SIMONE LANINI
Resubmission - Version 4
5 Mar 2012 Submitted Manuscript version 4
14 Mar 2012 Author responded Author comments - SIMONE LANINI
Resubmission - Version 5
14 Mar 2012 Submitted Manuscript version 5
Publishing
29 Mar 2012 Editorially accepted
29 Mar 2012 Article published 10.1186/1741-7015-10-31

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
National Institute for Infectious Diseases Lazzaro Spallanzani
(2)
Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories
(3)
Italian Health Cooperation

Advertisement